New in vitro model for the brain drug delivery research

Conditionally immortalized cell lines as novel models of the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB)

Tetsuya Terasaki, Satoko Hori, Suimio Ohtsuki, Tetsuya Terasaki, Satoko Hori, Sumio Ohtsuki, Tetsuya Terasaki, Satoko Hori, Sumio Ohtsuki

Research output: Contribution to journalArticle

Abstract

Elucidating the molecular mechanism of the brain barrier transport is a key step toward successful drug delivery to the brain. In this review, we focused on the usefulness and the limitations of the newly developed in vitro model. To overcome several limitations of classical in vitro model, conditionally immortalized mouse (TM-BBB) and rat (TR-BBB) brain capillary endothelial cell lines and a choroid plexus epithelial cell line (TR-CSFB) were established from the temperature sensitive SV 40 large T antigen gene transgenic animals. mRNA and protein expression of GLUT1 in TR-BBB was 100 folds greater than that of primary culture, Several known transporter genes were identified for TR-BBB or TM-BBB, including organic anion transporter 3 (OAT 3) and organic anion transporting polypeptide 2 (oatp 2). Employing TM-BBB, new brain barrier functions have been clarified such as creatine transporter (CRT) and GABA transporter (GAT 2/BGT-1). TR-BBB has been applied for the study of expressional regulation of transporters at the BBB, e. g., L-proline and glycine transporter (ATA 2) and taurine transporter (TAUT). Moreover, one of the most important subjects for the in vitro BBB model is to clarify the expression and regulation of the tight junction proteins at the BBB. Co-culture systems among TR-BBB, conditionally immortalized astrocyte (TR-AST) and pericyte (TR-PCT) cell lines were developed and revealed that the expression of occludin, a tight-junction component, was induced by soluble factors secreted from TR-AST and TR-PCT. For the brain drug delivery research, the new in vitro model will provide rational and efficient strategies.

Original languageEnglish
Pages (from-to)118-125
Number of pages8
JournalDrug Delivery System
Volume18
Issue number2
DOIs
Publication statusPublished - 2003 Jan 1
Externally publishedYes

Fingerprint

Blood-Brain Barrier
Cerebrospinal Fluid
Cell Line
Brain
Research
Pharmaceutical Preparations
Pericytes
In Vitro Techniques
Glycine Plasma Membrane Transport Proteins
Glucose Transporter Type 1
GABA Plasma Membrane Transport Proteins
Organic Anion Transporters
Occludin
Tight Junction Proteins
Genetically Modified Animals
Choroid Plexus
Tight Junctions
Viral Tumor Antigens
Coculture Techniques
Proline

Keywords

  • blood-brain barrier
  • blood-cerebrospinal fluid barrier
  • co-culture system
  • conditionally immortalized cell line
  • drug transporter

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

New in vitro model for the brain drug delivery research : Conditionally immortalized cell lines as novel models of the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB). / Terasaki, Tetsuya; Hori, Satoko; Ohtsuki, Suimio; Terasaki, Tetsuya; Hori, Satoko; Ohtsuki, Sumio; Terasaki, Tetsuya; Hori, Satoko; Ohtsuki, Sumio.

In: Drug Delivery System, Vol. 18, No. 2, 01.01.2003, p. 118-125.

Research output: Contribution to journalArticle

Terasaki, Tetsuya ; Hori, Satoko ; Ohtsuki, Suimio ; Terasaki, Tetsuya ; Hori, Satoko ; Ohtsuki, Sumio ; Terasaki, Tetsuya ; Hori, Satoko ; Ohtsuki, Sumio. / New in vitro model for the brain drug delivery research : Conditionally immortalized cell lines as novel models of the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB). In: Drug Delivery System. 2003 ; Vol. 18, No. 2. pp. 118-125.
@article{9f5f1980146c4eb8b316c608bc81be07,
title = "New in vitro model for the brain drug delivery research: Conditionally immortalized cell lines as novel models of the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB)",
abstract = "Elucidating the molecular mechanism of the brain barrier transport is a key step toward successful drug delivery to the brain. In this review, we focused on the usefulness and the limitations of the newly developed in vitro model. To overcome several limitations of classical in vitro model, conditionally immortalized mouse (TM-BBB) and rat (TR-BBB) brain capillary endothelial cell lines and a choroid plexus epithelial cell line (TR-CSFB) were established from the temperature sensitive SV 40 large T antigen gene transgenic animals. mRNA and protein expression of GLUT1 in TR-BBB was 100 folds greater than that of primary culture, Several known transporter genes were identified for TR-BBB or TM-BBB, including organic anion transporter 3 (OAT 3) and organic anion transporting polypeptide 2 (oatp 2). Employing TM-BBB, new brain barrier functions have been clarified such as creatine transporter (CRT) and GABA transporter (GAT 2/BGT-1). TR-BBB has been applied for the study of expressional regulation of transporters at the BBB, e. g., L-proline and glycine transporter (ATA 2) and taurine transporter (TAUT). Moreover, one of the most important subjects for the in vitro BBB model is to clarify the expression and regulation of the tight junction proteins at the BBB. Co-culture systems among TR-BBB, conditionally immortalized astrocyte (TR-AST) and pericyte (TR-PCT) cell lines were developed and revealed that the expression of occludin, a tight-junction component, was induced by soluble factors secreted from TR-AST and TR-PCT. For the brain drug delivery research, the new in vitro model will provide rational and efficient strategies.",
keywords = "blood-brain barrier, blood-cerebrospinal fluid barrier, co-culture system, conditionally immortalized cell line, drug transporter",
author = "Tetsuya Terasaki and Satoko Hori and Suimio Ohtsuki and Tetsuya Terasaki and Satoko Hori and Sumio Ohtsuki and Tetsuya Terasaki and Satoko Hori and Sumio Ohtsuki",
year = "2003",
month = "1",
day = "1",
doi = "10.2745/dds.18.118",
language = "English",
volume = "18",
pages = "118--125",
journal = "Drug Delivery System",
issn = "0913-5006",
publisher = "Japan Society of Drug Delivery System",
number = "2",

}

TY - JOUR

T1 - New in vitro model for the brain drug delivery research

T2 - Conditionally immortalized cell lines as novel models of the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB)

AU - Terasaki, Tetsuya

AU - Hori, Satoko

AU - Ohtsuki, Suimio

AU - Terasaki, Tetsuya

AU - Hori, Satoko

AU - Ohtsuki, Sumio

AU - Terasaki, Tetsuya

AU - Hori, Satoko

AU - Ohtsuki, Sumio

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Elucidating the molecular mechanism of the brain barrier transport is a key step toward successful drug delivery to the brain. In this review, we focused on the usefulness and the limitations of the newly developed in vitro model. To overcome several limitations of classical in vitro model, conditionally immortalized mouse (TM-BBB) and rat (TR-BBB) brain capillary endothelial cell lines and a choroid plexus epithelial cell line (TR-CSFB) were established from the temperature sensitive SV 40 large T antigen gene transgenic animals. mRNA and protein expression of GLUT1 in TR-BBB was 100 folds greater than that of primary culture, Several known transporter genes were identified for TR-BBB or TM-BBB, including organic anion transporter 3 (OAT 3) and organic anion transporting polypeptide 2 (oatp 2). Employing TM-BBB, new brain barrier functions have been clarified such as creatine transporter (CRT) and GABA transporter (GAT 2/BGT-1). TR-BBB has been applied for the study of expressional regulation of transporters at the BBB, e. g., L-proline and glycine transporter (ATA 2) and taurine transporter (TAUT). Moreover, one of the most important subjects for the in vitro BBB model is to clarify the expression and regulation of the tight junction proteins at the BBB. Co-culture systems among TR-BBB, conditionally immortalized astrocyte (TR-AST) and pericyte (TR-PCT) cell lines were developed and revealed that the expression of occludin, a tight-junction component, was induced by soluble factors secreted from TR-AST and TR-PCT. For the brain drug delivery research, the new in vitro model will provide rational and efficient strategies.

AB - Elucidating the molecular mechanism of the brain barrier transport is a key step toward successful drug delivery to the brain. In this review, we focused on the usefulness and the limitations of the newly developed in vitro model. To overcome several limitations of classical in vitro model, conditionally immortalized mouse (TM-BBB) and rat (TR-BBB) brain capillary endothelial cell lines and a choroid plexus epithelial cell line (TR-CSFB) were established from the temperature sensitive SV 40 large T antigen gene transgenic animals. mRNA and protein expression of GLUT1 in TR-BBB was 100 folds greater than that of primary culture, Several known transporter genes were identified for TR-BBB or TM-BBB, including organic anion transporter 3 (OAT 3) and organic anion transporting polypeptide 2 (oatp 2). Employing TM-BBB, new brain barrier functions have been clarified such as creatine transporter (CRT) and GABA transporter (GAT 2/BGT-1). TR-BBB has been applied for the study of expressional regulation of transporters at the BBB, e. g., L-proline and glycine transporter (ATA 2) and taurine transporter (TAUT). Moreover, one of the most important subjects for the in vitro BBB model is to clarify the expression and regulation of the tight junction proteins at the BBB. Co-culture systems among TR-BBB, conditionally immortalized astrocyte (TR-AST) and pericyte (TR-PCT) cell lines were developed and revealed that the expression of occludin, a tight-junction component, was induced by soluble factors secreted from TR-AST and TR-PCT. For the brain drug delivery research, the new in vitro model will provide rational and efficient strategies.

KW - blood-brain barrier

KW - blood-cerebrospinal fluid barrier

KW - co-culture system

KW - conditionally immortalized cell line

KW - drug transporter

UR - http://www.scopus.com/inward/record.url?scp=85024445307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024445307&partnerID=8YFLogxK

U2 - 10.2745/dds.18.118

DO - 10.2745/dds.18.118

M3 - Article

VL - 18

SP - 118

EP - 125

JO - Drug Delivery System

JF - Drug Delivery System

SN - 0913-5006

IS - 2

ER -